These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26653412)

  • 21. Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist.
    Hennen S; Wang H; Peters L; Merten N; Simon K; Spinrath A; Blättermann S; Akkari R; Schrage R; Schröder R; Schulz D; Vermeiren C; Zimmermann K; Kehraus S; Drewke C; Pfeifer A; König GM; Mohr K; Gillard M; Müller CE; Lu QR; Gomeza J; Kostenis E
    Sci Signal; 2013 Oct; 6(298):ra93. PubMed ID: 24150254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential signaling by splice variants of the human free fatty acid receptor GPR120.
    Watson SJ; Brown AJ; Holliday ND
    Mol Pharmacol; 2012 May; 81(5):631-42. PubMed ID: 22282525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
    Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
    Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictability of peripheral lymphocyte reduction of novel S1P1 agonists by in vitro GPCR signaling profile.
    Xu H; McElvain M; Fiorino M; Henkle B; Sherman L; Xu Y; Tominey E; Kelley K; Adlam M; Bürli R; Siu J; Wong M; Cee VJ
    J Biomol Screen; 2013 Oct; 18(9):997-1007. PubMed ID: 23686102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages.
    Im DS
    Eur J Pharmacol; 2016 Aug; 785():36-43. PubMed ID: 25987421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research.
    Li A; Li Y; Du L
    Future Med Chem; 2015; 7(11):1457-68. PubMed ID: 26230883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conformational signature of β-arrestin2 predicts its trafficking and signalling functions.
    Lee MH; Appleton KM; Strungs EG; Kwon JY; Morinelli TA; Peterson YK; Laporte SA; Luttrell LM
    Nature; 2016 Mar; 531(7596):665-8. PubMed ID: 27007854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.
    Zhao P; Sharir H; Kapur A; Cowan A; Geller EB; Adler MW; Seltzman HH; Reggio PH; Heynen-Genel S; Sauer M; Chung TD; Bai Y; Chen W; Caron MG; Barak LS; Abood ME
    Mol Pharmacol; 2010 Oct; 78(4):560-8. PubMed ID: 20826425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay.
    Hamdan FF; Audet M; Garneau P; Pelletier J; Bouvier M
    J Biomol Screen; 2005 Aug; 10(5):463-75. PubMed ID: 16093556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
    van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders.
    Moniri NH
    Biochem Pharmacol; 2016 Jun; 110-111():1-15. PubMed ID: 26827942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.
    Burns RN; Singh M; Senatorov IS; Moniri NH
    Biochem Pharmacol; 2014 Feb; 87(4):650-9. PubMed ID: 24412271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and target-pathway deconvolution of FFA4 agonists with anti-diabetic activity from Arnebia euchroma (Royle) Johnst.
    Xu F; Wang P; Zhang X; Hou T; Qu L; Wang C; Wang J; Liu Y; Liang X
    Pharmacol Res; 2021 Jan; 163():105173. PubMed ID: 33027715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science.
    Son SE; Kim NJ; Im DS
    Biomol Ther (Seoul); 2021 Jan; 29(1):22-30. PubMed ID: 33372166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
    Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
    FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviors.
    Brulé C; Perzo N; Joubert JE; Sainsily X; Leduc R; Castel H; Prézeau L
    FASEB J; 2014 Dec; 28(12):5148-62. PubMed ID: 25183668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120).
    Hansen SV; Ulven T
    Handb Exp Pharmacol; 2017; 236():33-56. PubMed ID: 27807695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation.
    Im DS
    Mol Aspects Med; 2018 Dec; 64():92-108. PubMed ID: 28887275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrestins in the cardiovascular system.
    Lymperopoulos A; Bathgate A
    Prog Mol Biol Transl Sci; 2013; 118():297-334. PubMed ID: 23764059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.